BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37553578)

  • 21. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy.
    Seo M; Choi Y; Soo Lee Y; Ahn KJ; Kim BS; Park JS; Jeon SS
    Eur J Radiol; 2023 Aug; 165():110888. PubMed ID: 37257338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revealing tumor microstructure with oscillating diffusion encoding MRI in pre-surgical and post-treatment glioma patients.
    Zhu A; Shih R; Huang RY; DeMarco JK; Bhushan C; Morris HD; Kohls G; Yeo DTB; Marinelli L; Mitra J; Hood M; Ho VB; Foo TKF
    Magn Reson Med; 2023 Nov; 90(5):1789-1801. PubMed ID: 37335831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation between glioblastoma and solitary brain metastasis using neurite orientation dispersion and density imaging.
    Kadota Y; Hirai T; Azuma M; Hattori Y; Khant ZA; Hori M; Saito K; Yokogami K; Takeshima H
    J Neuroradiol; 2020 May; 47(3):197-202. PubMed ID: 30439396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
    Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
    Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic role of apparent diffusion coefficient combined with intratumoral susceptibility signals in differentiating high-grade gliomas from brain metastases.
    Bozdağ M; Er A; Çinkooğlu A; Ekmekçi S
    Neuroradiol J; 2021 Jun; 34(3):169-179. PubMed ID: 33307971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
    Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioblastoma multiforme with atypical diffusion-weighted MR findings.
    Hakyemez B; Erdogan C; Yildirim N; Parlak M
    Br J Radiol; 2005 Nov; 78(935):989-92. PubMed ID: 16249598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of conventional magnetic resonance imaging and diffusion-weighted imaging in the differentiation of bone plasmacytoma from bone metastasis in the extremities.
    Hwang H; Lee SK; Kim JY
    Diagn Interv Imaging; 2021 Oct; 102(10):611-618. PubMed ID: 34127433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.
    Chawla S; Wang S; Mohan S; Nasrallah M; Verma G; Brem S; O'Rourke DM; Wolf RL; Poptani H; Nabavizadeh SA
    J Magn Reson Imaging; 2019 Jan; 49(1):184-194. PubMed ID: 29676844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
    van Dijken BRJ; Jan van Laar P; Li C; Yan JL; Boonzaier NR; Price SJ; ; van der Hoorn A
    J Neurosurg; 2018 Oct; 131(3):717-723. PubMed ID: 30485234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
    Feng A; Yuan P; Huang T; Li L; Lyu J
    Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apparent diffusion coefficient in the evaluation of cerebral gliomas malignancy.
    Ignjatović J; Stojanov D; Zivković V; Ljubisavljević S; Stojanović N; Stefanović I; Benedeto-Stojanović D; Ignjatović N; Petrović S; Aracki-Trenkić A; Radovanović Z; Lazović L
    Vojnosanit Pregl; 2015 Oct; 72(10):870-5. PubMed ID: 26665552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diffusion-weighted MRI in the differentiation of brain abscesses and necrotic tumors].
    Hakyemez B; Ergin N; Uysal S; Işik I; Kiliç E
    Tani Girisim Radyol; 2004 Jun; 10(2):110-8. PubMed ID: 15236124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination Between Glioblastoma and Solitary Brain Metastasis Using Conventional MRI and Diffusion-Weighted Imaging Based on a Deep Learning Algorithm.
    Yan Q; Li F; Cui Y; Wang Y; Wang X; Jia W; Liu X; Li Y; Chang H; Shi F; Xia Y; Zhou Q; Zeng Q
    J Digit Imaging; 2023 Aug; 36(4):1480-1488. PubMed ID: 37156977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
    Choi YS; Lee HJ; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
    Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation among Glioblastomas, Primary Cerebral Lymphomas, and Solitary Brain Metastases Using Diffusion-Weighted Imaging and Diffusion Tensor Imaging: A PRISMA-Compliant Meta-analysis.
    Zhang P; Liu B
    ACS Chem Neurosci; 2020 Feb; 11(3):477-483. PubMed ID: 31922391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discriminating glioblastoma from solitary brain metastases on 3 Tesla magnetic resonance imaging: the roles of fractional anisotropy and mean diffusivity.
    Nguyen DH; Le TD; Nguyen HV; Nguyen-Thi VA; Nguyen DH; Dong-Van H; Nguyen MD
    Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8823-8831. PubMed ID: 36524501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.
    Han Q; Lu Y; Wang D; Li X; Ruan Z; Mei N; Ji X; Geng D; Yin B
    Eur Radiol; 2023 Dec; 33(12):9139-9151. PubMed ID: 37495706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions.
    Lin L; Xue Y; Duan Q; Sun B; Lin H; Huang X; Chen X
    Oncotarget; 2016 Oct; 7(42):69051-69059. PubMed ID: 27655705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.